Symptoms of inflammatory bowel disease (IBD) are chronic and are characterized by periodic exacerbations followed by symptom-free intervals. Symptoms can have a detrimental impact on quality of life. Medication non-adherence in adults with IBD has been well-documented in the literature; continuous medication use is necessary to prevent flares of the disease. Therefore, the purpose of the present study was three-fold: (1) to examine associations between medication non-adherence, disease activity, and health-related quality of life (HRQOL), (2) to examine if group differences were present for patients who were high versus low in anxiety or depression in terms of their medication non-adherence, disease activity and HRQOL, and (3) to examine the contributions of coping and social constraint on disclosure to medication non-adherence, disease activity, and HRQOL. The present study was retrospective; 80 patients with IBD completed questionnaires, as part of routine care in a tertiary referral center. Results demonstrated a negative association between disease activity and HRQOL. Medication non-adherence was not associated with disease activity. In addition, patients high in anxiety or depression had diminished quality of life compared to patients low in anxiety. Regression results did not support the hypothesis that social constraint moderated the relationship between coping and HRQOL; however, the use of engagement coping approached negative significance with HRQOL. Regressions testing the mediating effects of medication non-adherence on the relations between both social constraint and coping on disease activity were not performed because results showed that medication non-adherence was not significantly related to disease activity. Results did reveal that participants who reported increased social constraint reported increased intentional and unintentional non-adherence. Also, disengagement coping significantly contributed to disease activity. In conclusion, the present study adds to the current knowledge regarding the role of both coping and social constraint in individuals with IBD. Future research is warranted to clarify the role of coping and social constraint on medication nonadherence, HRQOL, and disease activity.
|Advisor:||Halpern, Leslie F.|
|Commitee:||Cross, Raymond, Danoff-Burg, Sharon|
|School:||State University of New York at Albany|
|School Location:||United States -- New York|
|Source:||DAI-B 71/05, Dissertation Abstracts International|
|Subjects:||Health sciences, Clinical psychology|
|Keywords:||Coping, Disease activity, HRQOL, Health-related quality of life, Inflammatory bowel disease, Psychological distress, Social constraint|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be